Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17207439 | 0.99 | ACHE (0.34) | ACHEGAAHSD17B10SLC6A2SLC6A4 | |
| SCHEMBL17207377 | 0.96 | ACHE (0.35) | ACHEGAAHSD17B10SLC18A3CYP19A1 | |
| SCHEMBL17207394 | 0.90 | ACHE (0.33) | ACHEGAAHSD17B10SLC6A2SLC6A4 | |
| SCHEMBL17207427 | 0.89 | GAA (0.33) | ACHEGAAHSD17B10SLC6A2SLC6A4 | |
| SCHEMBL17207376 | 0.86 | ACHE (0.34) | ACHEGAAHSD17B10CYP19A1CYP17A1 | |
| SCHEMBL17207398 | 0.81 | ACHE (0.37) | ACHEGAAHSD17B10SLC6A2SLC6A4 | |
| SCHEMBL17207371 | 0.80 | SLC6A4 (0.39) | ACHEGAAHSD17B10SLC6A2SLC6A4 | |
| SCHEMBL17207445 | 0.80 | ACHE (0.36) | ACHEGAAHSD17B10SLC6A2SLC6A4 | |
| SCHEMBL15834041 | 0.79 | SLC6A9 (0.43) | SLC18A3SLC6A9OPRM1 | |
| SCHEMBL17207431 | 0.79 | SLC6A4 (0.39) | ACHEGAAHSD17B10SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150307460-A1 | Substituted Triazoles and Imidazoles and Their Use as Fungicides | BASF SE (DE) | 2015-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150307460-A1 | Substituted Triazoles and Imidazoles and Their Use as Fungicides | TH, CYP51A1, NOS3 | ACHE 2655/4885GAA 1136/4885HSD17B10 3328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.